Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAK in Quinolone Eyedrops and Resistance
NCT00874887Phase 4Completed
- Sponsor
- Allergan
- Start
- Mar 2009
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of gatifloxacin in bacterial conjunctivitis (BC), sponsored by Allergan. Started Mar 2009; status: completed.
02
Drugs
gatifloxacin
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on NCT00874887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00874887.